Hannah Batchelor

Has grant

University of Birmingham

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

The cystic fibrosis (CF) anti-staphylococcal antibiotic prophylaxis trial (CF START); a randomised registry trial to assess the safety and efficacy of flucloxacillin as a longterm prophylaxis agent for infants with CF

Open Date: 2016-08-01

Close Date: 2025-07-31

Grant: Close

Accelerating paediatric formulation development through smart design and predictive science

Open Date: 2014-06-30

Close Date: 2018-03-30

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (8)

Nicholas Rattray

University Of Strathclyde

UNITED KINGDOM

View details

Maria Alexandra Ribeiro

Prof

Universidade Nova de Lisboa, NOVA Medical School | Faculdade de Ciências Médicas

PORTUGAL

View details

Richard Horniblow

University of Birmingham

UNITED KINGDOM

View details

Sveinbjorn Gizurarson

ICELAND

View details

Konstantinos Stamatopoulos

GlaxoSmithKline (United States)

UNITED KINGDOM

View details

Mark Simmons

University of Birmingham

UNITED KINGDOM

View details

Catherine Tuleu

UCL School of Pharmacy

UNITED KINGDOM

View details

Fotis Spyropoulos

University of Birmingham

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hannah Batchelor

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (11)

Quantification of drug metabolising enzymes and transporter proteins in the paediatric duodenum via LC-MS/MS proteomics using a QconCAT technique

Colour of Medicines and Children’s Acceptability? A Systematic Literature Review of Children’s Perceptions about Colours of Oral Dosage Forms

Optimizing expert and patient input in pediatric trial design

Integration of biorelevant pediatric dissolution methodology into PBPK modeling to predict in vivo performance and bioequivalence of generic drugs in pediatric populations

Use of In Vitro Dynamic Colon Model (DCM) to Inform a Physiologically Based Biopharmaceutic Model (PBBM) to Predict the In Vivo Performance of a Modified-Release Formulation of Theophylline

Solid lipid nanoparticles and nanostructured lipid carriers of dual functionality at emulsion interfaces. Part II

Study of in vitro poorly soluble drug solubility into fasted state simulated intestinal fluid reflective of in vivo gastrointestinal variability

Solid lipid nanoparticles and nanostructured lipid carriers of dual functionality at emulsion interfaces. Part I

Development of a digital twin of a tablet that mimics a real solid dosage form

Solubility measurement of poorly soluble drugs in fasted state simulated intestinal fluid

The Effect of Biorelevant Hydrodynamic Conditions on Drug Dissolution from Extended-Release Tablets in the Dynamic Colon Model

Collaborators (8)

Nicholas Rattray

Maria Alexandra Ribeiro

Richard Horniblow

Sveinbjorn Gizurarson

Konstantinos Stamatopoulos

Mark Simmons

Catherine Tuleu

Fotis Spyropoulos

Make your next move.